ViroGates (Denmark) Performance
| VIRO Stock | 8.55 0.20 2.29% |
The entity has a beta of -0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ViroGates are expected to decrease at a much lower rate. During the bear market, ViroGates is likely to outperform the market. At this point, ViroGates AS has a negative expected return of -0.37%. Please make sure to validate ViroGates' kurtosis, daily balance of power, and the relationship between the skewness and accumulation distribution , to decide if ViroGates AS performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days ViroGates AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 33.5 M | |
| Total Cashflows From Investing Activities | -4000.00 |
ViroGates |
ViroGates Relative Risk vs. Return Landscape
If you would invest 1,190 in ViroGates AS on December 21, 2024 and sell it today you would lose (335.00) from holding ViroGates AS or give up 28.15% of portfolio value over 90 days. ViroGates AS is generating negative expected returns and assumes 6.3999% volatility on return distribution over the 90 days horizon. Simply put, 57% of stocks are less volatile than ViroGates, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ViroGates Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ViroGates' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ViroGates AS, and traders can use it to determine the average amount a ViroGates' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0571
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VIRO |
Estimated Market Risk
| 6.4 actual daily | 57 57% of assets are less volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ViroGates is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ViroGates by adding ViroGates to a well-diversified portfolio.
ViroGates Fundamentals Growth
ViroGates Stock prices reflect investors' perceptions of the future prospects and financial health of ViroGates, and ViroGates fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ViroGates Stock performance.
| Return On Equity | -0.62 | |||
| Return On Asset | -0.39 | |||
| Profit Margin | (1.13) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 122.74 M | |||
| Shares Outstanding | 3.35 M | |||
| Price To Book | 7.49 X | |||
| Price To Sales | 16.38 X | |||
| Revenue | 7.66 M | |||
| EBITDA | (18.55 M) | |||
| Book Value Per Share | 5.34 X | |||
| Cash Flow From Operations | (21.44 M) | |||
| Earnings Per Share | (5.16) X | |||
| Total Asset | 20.23 M | |||
About ViroGates Performance
By examining ViroGates' fundamental ratios, stakeholders can obtain critical insights into ViroGates' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ViroGates is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about ViroGates AS performance evaluation
Checking the ongoing alerts about ViroGates for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ViroGates AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ViroGates AS generated a negative expected return over the last 90 days | |
| ViroGates AS has high historical volatility and very poor performance | |
| ViroGates AS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.66 M. Net Loss for the year was (17.66 M) with profit before overhead, payroll, taxes, and interest of 5.79 M. | |
| ViroGates generates negative cash flow from operations | |
| About 50.0% of the company outstanding shares are owned by insiders |
- Analyzing ViroGates' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ViroGates' stock is overvalued or undervalued compared to its peers.
- Examining ViroGates' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ViroGates' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ViroGates' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ViroGates' stock. These opinions can provide insight into ViroGates' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in ViroGates Stock
ViroGates financial ratios help investors to determine whether ViroGates Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ViroGates with respect to the benefits of owning ViroGates security.